Publikationen, an denen er mitarbeitet Cristóbal Belda Iniesta (3)

2018

  1. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

    The Lancet Oncology, Vol. 19, Núm. 4, pp. 521-536

2013

  1. Lung adenocarcinoma in the era of targeted therapies: Histological classification, sample prioritization, and predictive biomarkers

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 503-508

2010

  1. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer

    Oncogene, Vol. 29, Núm. 11, pp. 1681-1690